LOS ANGELES, June 12, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. GeneDx is the subject of a report published by Grizzly Research on February 5, 2025, titled: "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report claims that the Company's "growth is largely an illusion, driven by fraudulent schemes and illegal tactics deliberately aimed at exploiting Medicaid and Medicare systems to inflate revenue artificially." The report alleges that, "testimonies from former employees and ongoing litigation suggest that GeneDx has inflated its revenue through an illegal practice known as 'code stacking,'" which "enables the company to bill insurance providers for services that do not meet the required criteria." The report also claims that "CEO Katherine Stueland and CFO Kevin Feeley have consistently sold their shares immediately upon vesting, without ever engaging in open market purchases," a "pattern suggest[ing] that insiders may be aware of an imminent risk that will significantly impact the company."

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com

www.schallfirm.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wgs-investors-have-opportunity-to-join-genedx-holdings-corp-fraud-investigation-with-the-schall-law-firm-302480602.html

SOURCE The Schall Law Firm